FDA Brief

Warning letters Drugs

FDA warning letter to

Nexlife Inc. dba Nexlife

LowIssued Jun 8Posted Jun 16Center for Drug Evaluation and Research (CDER)

FDA warned Nexlife that its website labels for compounded semaglutide and tirzepatide falsely suggest Nexlife is the compounder.

What happened

During a March 2026 review of Nexlife’s website, FDA found offers of compounded semaglutide and tirzepatide products. The pictured labels showed “Nexlife” as if Nexlife made the drugs, but FDA says it is not the compounder. FDA cited this as false or misleading labeling and advertising.

What FDA found

  1. The website labels for compounded semaglutide and tirzepatide show “Nexlife” in a way that suggests Nexlife made the drugs, but it did not.

    FD&C Act § 502(a) [21 U.S.C. § 352(a)]
  2. The website’s promotion of these compounded drugs is false or misleading.

    FD&C Act § 502(bb) [21 U.S.C. § 352(bb)]
  3. The drugs were sent or offered for shipment across state lines in violation of the law.

    FD&C Act § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA asks Nexlife to respond within 15 business days with steps taken, including identifying who produces the compounded drugs, providing sample labeling, and fixing or removing other false or misleading website claims.

Who should pay attention

  • telehealth companies selling compounded semaglutide or tirzepatide
  • online pharmacies and website marketers of compounded drugs
  • contract manufacturers whose products are labeled with another firm’s name

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low